# Treatment of Pseudovitellium Detachment With Open-Label Anecortave Acetate Sterile Suspension (15 mg)

> **NCT00211432** · PHASE2 · COMPLETED · sponsor: **Manhattan Eye, Ear & Throat Hospital** · enrollment: 4 (actual)

## Conditions studied

- Pseudovitellium Detachment
- Eye Diseases

## Interventions

- **DRUG:** Anecortave Acetate Sterile Suspension (15 mg)

## Key facts

- **NCT ID:** NCT00211432
- **Lead sponsor:** Manhattan Eye, Ear & Throat Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04
- **Primary completion:** 2010-04
- **Final completion:** 2010-04
- **Target enrollment:** 4 (ACTUAL)
- **Last updated:** 2012-10-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00211432

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00211432, "Treatment of Pseudovitellium Detachment With Open-Label Anecortave Acetate Sterile Suspension (15 mg)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00211432. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*